Must-Knows of Fraud Investigations into ACB and CGC

Several prominent law firms have launched investigations into ACB and CGC for potentially violating federal securities law.

What Are Leon Cooperman’s Top Holdings?

In Q3, billionaire investor Leon Cooperman's top five holdings were Fiserv, Alphabet, United Continental, Chimera Investment, and Cigna.

ACB Sees Third-Worst Day in Years: What Analysts Think

On November 18, Aurora Cannabis (ACB) closed at 3 Canadian dollars on the TSX, a 16.43% drop and the third-worst trading day for it in three years.

Amazon Pharmacy, AWS Data Exchange, and JEDI

According to Gartner’s research published in April 2019, the estimated share of the cloud business segment could cross $300 billion by 2022.
Canopy Growth

Will the Dow Jones Industrial Average Climb to 30,000?

The Dow Jones Industrial Average (DJIA) (DIA) seems to be touching new highs despite pessimism related to progress in trade talks.

David Tepper’s Appaloosa: Analyzing Its Top Holdings

In the third quarter, David Tepper's Appaloosa included three new stocks, exited five securities, and increased its stake in the existing eight stocks.

MedMen Fights for Survival amid Sector Meltdown

On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.
George Soros

The George Soros Fund Shares 13F Analysis

On November 14, The George Soros Fund Management LLC filed 13F. The firm's total market value was around $3.6 billion at the end of Q3 2019.
Amarin stock

How Much Higher Can Amarin Stock Surge?

In the November 15 premarket trading session, Amarin Corporation (AMRN) stock rose more than 7%, caused by the FDA positive decision for Vascepa.